FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004221544> ?p ?o ?g. }

• W2004221544 endingPage "1605" @default.
• W2004221544 startingPage "1598" @default.
• W2004221544 abstract "After in vivo administration, propylthiouracil (PTU) inhibits not only thyroid iodide uptake and organification, but also T4 5'-deiodinase activity in most peripheral organs. The present report describes the effects of some previously untested 6-substituted 2-thiouracil derivatives on in vivo and in vitro iodide uptake and organification, and on T4 5'-deiodinase activity in liver and pituitary homogenates. When added to homogenates, many analogs were as potent or more potent than PTU in inhibiting hepatic T4 5'-deiodinase activity. Three derivatives, 6-anilino-2-thiouracil (A compound), 6-(p-ethylanilino)2-thiouracil (B compound), and 6-(p-n-butylanilino) 2-thiouracil (C compound), which were among the most potent inhibitors of hepatic T4 5'-deiodinase, when added in vitro inhibited T4 5'-deiodinase activity in liver homogenates after in vivo administration. When added to pituitary homogenates prepared from hypothyroid rats, these compounds also significantly inhibited pituitary T4 5'-deiodinase activity. In a concentration of 1 mM in the presence of 20 mM dithiothreitol, the percent inhibition of pituitary T4 5'-deiodinase activity was 19.7 +/- 7.4 (mean +/- SE), 34.0 +/- 3.2, 47.3 +/- 3.1, and 89.0 +/- 1.0 for PTU and the A, B, and C compounds, respectively (P less than 0.05 for all groups vs. one another and vehicle). Despite their ability to inhibit hepatic T4 5'-deiodinase activity, none of the 13 analogs tested altered thyroid iodide uptake or organification after administration of 0.1 mg/rat. PTU, in the same dose, inhibited thyroid iodide uptake by 78.2 +/- 2.4% (P less than 0.001) and thyroid iodide organification by 36.4 +/- 7.3% (P less than 0.01). Furthermore, the A, B, and C compounds did not inhibit thyroid iodide uptake or iodide organification when administered in higher doses of 5, 5, and 1 mg/rat, respectively. In contrast to these in vivo results, the A, B, and C compounds were more potent than PTU in inhibiting iodide organification in a purified thyroid peroxidase system and in porcine thyroid slices. The concentrations causing 50% inhibition of iodide organification in the purified thyroid peroxidase system were 30, 7, 8, and 14 microM for PTU and the A, B, and C compounds, respectively. However, PTU was far more potent in inhibiting iodide organification in intact incubated thyroid lobes compared to the A, B, and C compounds.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2004221544 created "2016-06-24" @default.
• W2004221544 creator A5008850347 @default.
• W2004221544 creator A5008870057 @default.
• W2004221544 creator A5036514118 @default.
• W2004221544 creator A5072728955 @default.
• W2004221544 creator A5073970977 @default.
• W2004221544 creator A5074547550 @default.
• W2004221544 date "1986-04-01" @default.
• W2004221544 modified "2023-10-01" @default.
• W2004221544 title "A New Class of Propylthiouracil Analogs: Comparison of 5'-Deiodinase Inhibition and Antithyroid Activity*" @default.
• W2004221544 cites W1758817371 @default.
• W2004221544 cites W1969737280 @default.
• W2004221544 cites W1979693058 @default.
• W2004221544 cites W1994774080 @default.
• W2004221544 cites W1997378330 @default.
• W2004221544 cites W2005413971 @default.
• W2004221544 cites W2034778853 @default.
• W2004221544 cites W2037176881 @default.
• W2004221544 cites W2038544507 @default.
• W2004221544 cites W2041459249 @default.
• W2004221544 cites W2041515204 @default.
• W2004221544 cites W2049802040 @default.
• W2004221544 cites W2051726957 @default.
• W2004221544 cites W2061778079 @default.
• W2004221544 cites W2062149448 @default.
• W2004221544 cites W2071064342 @default.
• W2004221544 cites W2082900804 @default.
• W2004221544 cites W2084429552 @default.
• W2004221544 cites W2106173832 @default.
• W2004221544 cites W2108100626 @default.
• W2004221544 cites W2111621105 @default.
• W2004221544 cites W2120496461 @default.
• W2004221544 cites W2130469339 @default.
• W2004221544 cites W2131377884 @default.
• W2004221544 cites W2142623819 @default.
• W2004221544 cites W2269110264 @default.
• W2004221544 doi "https://doi.org/10.1210/endo-118-4-1598" @default.
• W2004221544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3948793" @default.
• W2004221544 hasPublicationYear "1986" @default.
• W2004221544 type Work @default.
• W2004221544 sameAs 2004221544 @default.
• W2004221544 citedByCount "14" @default.
• W2004221544 countsByYear W20042215442013 @default.
• W2004221544 countsByYear W20042215442021 @default.
• W2004221544 countsByYear W20042215442022 @default.
• W2004221544 countsByYear W20042215442023 @default.
• W2004221544 crossrefType "journal-article" @default.
• W2004221544 hasAuthorship W2004221544A5008850347 @default.
• W2004221544 hasAuthorship W2004221544A5008870057 @default.
• W2004221544 hasAuthorship W2004221544A5036514118 @default.
• W2004221544 hasAuthorship W2004221544A5072728955 @default.
• W2004221544 hasAuthorship W2004221544A5073970977 @default.
• W2004221544 hasAuthorship W2004221544A5074547550 @default.
• W2004221544 hasConcept C126322002 @default.
• W2004221544 hasConcept C134018914 @default.
• W2004221544 hasConcept C150903083 @default.
• W2004221544 hasConcept C171269688 @default.
• W2004221544 hasConcept C185592680 @default.
• W2004221544 hasConcept C207001950 @default.
• W2004221544 hasConcept C2775960720 @default.
• W2004221544 hasConcept C2776501357 @default.
• W2004221544 hasConcept C2776606491 @default.
• W2004221544 hasConcept C2776652619 @default.
• W2004221544 hasConcept C2778288131 @default.
• W2004221544 hasConcept C2778417266 @default.
• W2004221544 hasConcept C2779123554 @default.
• W2004221544 hasConcept C526584372 @default.
• W2004221544 hasConcept C71924100 @default.
• W2004221544 hasConcept C86803240 @default.
• W2004221544 hasConceptScore W2004221544C126322002 @default.
• W2004221544 hasConceptScore W2004221544C134018914 @default.
• W2004221544 hasConceptScore W2004221544C150903083 @default.
• W2004221544 hasConceptScore W2004221544C171269688 @default.
• W2004221544 hasConceptScore W2004221544C185592680 @default.
• W2004221544 hasConceptScore W2004221544C207001950 @default.
• W2004221544 hasConceptScore W2004221544C2775960720 @default.
• W2004221544 hasConceptScore W2004221544C2776501357 @default.
• W2004221544 hasConceptScore W2004221544C2776606491 @default.
• W2004221544 hasConceptScore W2004221544C2776652619 @default.
• W2004221544 hasConceptScore W2004221544C2778288131 @default.
• W2004221544 hasConceptScore W2004221544C2778417266 @default.
• W2004221544 hasConceptScore W2004221544C2779123554 @default.
• W2004221544 hasConceptScore W2004221544C526584372 @default.
• W2004221544 hasConceptScore W2004221544C71924100 @default.
• W2004221544 hasConceptScore W2004221544C86803240 @default.
• W2004221544 hasIssue "4" @default.
• W2004221544 hasLocation W20042215441 @default.
• W2004221544 hasLocation W20042215442 @default.
• W2004221544 hasOpenAccess W2004221544 @default.
• W2004221544 hasPrimaryLocation W20042215441 @default.
• W2004221544 hasRelatedWork W1995863837 @default.
• W2004221544 hasRelatedWork W2004221544 @default.
• W2004221544 hasRelatedWork W2055124061 @default.
• W2004221544 hasRelatedWork W2070995469 @default.
• W2004221544 hasRelatedWork W2089403276 @default.
• W2004221544 hasRelatedWork W2163236351 @default.
• W2004221544 hasRelatedWork W2172055973 @default.

• next